Back to Search
Start Over
Lexent Bio Announces Use of its Liquid Biopsy Assay, Confera Dx, in a Peer-Reviewed Paper Published in the Journal Molecular Cancer Therapeutics
- Source :
- Cancer Weekly. May 26, 2020, 88
- Publication Year :
- 2020
-
Abstract
- 2020 MAY 26 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Lexent Bio, Inc., a precision oncology company developing novel liquid biopsy systems, announced the use [...]
Details
- Language :
- English
- ISSN :
- 15324567
- Database :
- Gale General OneFile
- Journal :
- Cancer Weekly
- Publication Type :
- News
- Accession number :
- edsgcl.624764665